絞り込み

16532

広告

Denosumab-induced normocalcemic hyperparathyroidismin in a woman with postmenopausal osteoporosis and normal renal function.

著者 Mazokopakis EE
Curr Drug Saf.2018 Jun 07 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (33view , 0users)

Full Text Sources

Elevations in serum parathyroid hormone (PTH) levels after denosumab administration have been described in medical literature among patients with renal impairment or intestinal malabsortion syndromes. We present the first case of denosumab-induced normocalcemic hyperparathyroidism in a woman with postmenopausal osteoporosis without renal impairment or malabsorption syndrome.
PMID: 29879891 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード